Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: rllee who wrote (35472)	9/27/2009 4:05:50 PM
From: Arthur Radley	Read Replies (1) \| Respond to of 78748

Raw doesn't want to talk about those issues........but for the record, institutions have DUMPED about 25 million share in this jewel in latest reporting. Ask Raw, how much this operation lost in 2007, 2008, and so far this year reporting even greater losses. And now SEC questions have stopped dead in the water their plans to hold something called Annual Stockholder meeting. He mocks ETMR, however, ask him how many shares the insiders and institutions have BOUGHT in the last few months....as I have. Biotech don't have income until they get product approved by the FDA...Let's see, RIOAK is trading for .85 cents, and ETMR was trading at .83 cents a few months ago and is now trading a $5.00....so one should ask......if it's at $5.00 how much will it be worth if they get FDA approval for addressing one of the nation/world's great health crisis. Raw paints the 'pie-in-the-sky' story.....I tell anyone...do your own DD.

To: rllee who wrote (35472)	9/27/2009 4:15:56 PM
From: Rawnoc	Respond to of 78748

I'll bet Ariel threw up their lunch when they saw the earnings report out of ROIAK along with their forecast of it being at a bottom and disclosure of some massive share buybacks. :) It's too bad they aren't joining the fat drug fad though.....LOL